Stelios Chatzimichail, is a specialist physician in Intensive Care Medicine and Emergency Medicine with 18 years of clinical experience. He earned his Bachelor of Science degree from Denison University in Granville, Ohio, and his medical degree from the University of Aberdeen in Aberdeen, Scotland.

Throughout his career, Dr. Chatzimichail has been actively involved in evidence-based practice and quality improvement initiatives, developing and implementing clinical protocols to support the safe delivery of care across both medical and surgical specialties. He has a particular interest in preventative medicine and innovative approaches to improving long-term patient outcomes.

He is the founder of Choju Nutraceuticals, a startup focused on developing bespoke medicines and advanced delivery mechanisms. In addition, Dr. Chatzimichail has provided consultancy services to multiple medical device and healthcare technology companies.

By combining frontline clinical experience with strategic insight, he collaborates with healthcare technology and medical device innovators to bridge the gap between clinical medicine and technological advancement. His work centers on proof-of-concept evaluation, clinical applicability, and the integration of new technologies into real-world patient care environments, ensuring solutions are both scientifically sound and clinically practical.